Optimization of Potent and Selective Ataxia Telangiectasia-Mutated Inhibitors Suitable for a Proof-of-Concept Study in Huntington's Disease Models.
Toledo-Sherman, L., Breccia, P., Cachope, R., Bate, J.R., Angulo-Herrera, I., Wishart, G., Matthews, K.L., Martin, S.L., Cox, H.C., McAllister, G., Penrose, S.D., Vater, H., Esmieu, W., Van de Poel, A., Van de Bospoort, R., Strijbosch, A., Lamers, M., Leonard, P., Jarvis, R.E., Blackaby, W., Barnes, K., Eznarriaga, M., Dowler, S., Smith, G.D., Fischer, D.F., Lazari, O., Yates, D., Rose, M., Jang, S.W., Munoz-Sanjuan, I., Dominguez, C.
J.Med.Chem.